2Salerno F, Gerbes A, Gines P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis [ J ]. Gut,2007,56 (9):1 310-1318. 被引量：1
2ARROYO V,GINES P,GERBES AL,et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis[J]. Hepatology, 1996,23 : 164. 被引量：1
3SCHRIER RW,ARROYO V,BERNARDI M,et al. Peripheral arterial vasodilation hypothesis:a proposal for the initiation of renal sodium and water retention in cirrhosis I J]. Hepatology, 1988,8(5 ) : 1151. 被引量：1
4GUARNER C,SORIANO G,TOMAS A,et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxaemia[J]. Heptology, 1993,18:1139. 被引量：1
5SOGNI P,GARMIER P,GADANO A,et al. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis[J]. J Heptol, 1995,329: 2002. 被引量：1
6MONCADA S,HIGGS A. The L-arginine-nitrix oxide pathway[J]. N Engl J Med,1991,329:2002. 被引量：1
7GUEVARA M,GINES P,JIMENEZ W,et al. Increased adrenomedullin levels in cirrhosis:relationship with hemodynamic abnormalities and vasoconstrictor systems [J]. Gastroenterology, 1998,114(2) : 336. 被引量：1
8FERNADEZ -RODRIGUEZC M,PRADA IR,PRIETO J,et al. Circulating adrenomedullin in cirrhosis:Relationship to hyperdynamic circulation[J]. J Hepatol, 1998,29: 250. 被引量：1
9WONG F,BLENDIS drome: prevention and 1242. L. New hallenge of atorenal syn- treatment [J]. Hepatology,2001,34: 被引量：1
10EPSTEIN M,GOLIGORSKY MS. Endothelin and nitric oxide in hepatorenal syndrome:A balance reset [J]. J Nephrol, 1997, 10:120. 被引量：1
